Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 20 | 0 | 3 | 0 | €101.10 | €116.25 | 14.983% |
| Eli Lilly Corp. | 66 | 0 | 7 | 0 | €846.10 | €841.20 | -0.579% |
| Amgen Inc. | 28 | 0 | 4 | 0 | €296.40 | €304.82 | 2.840% |
| AbbVie Inc. | 33 | 0 | 7 | 0 | €176.26 | €180.36 | 2.326% |
| Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | €31.86 | €36.87 | 15.719% |
| Exact Sciences | 17 | 0 | 2 | 0 | €53.30 | €75.89 | 42.385% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Repligen Corp. | 15 | 0 | 4 | 0 | €148.25 | €178.01 | 20.076% |
| Immunogen Inc. | 3 | 0 | 0 | 0 | €28.97 | - | - |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €22.60 | €28.29 | 25.180% |
| Biocryst Pharmaceuticals | 7 | 0 | 1 | 0 | €6.95 | €11.13 | 60.178% |
| Neurocrine Bioscience | 42 | 0 | 10 | 0 | €134.65 | €149.47 | 11.008% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.07 | €5.54 | 36.051% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €121.30 | €130.00 | 7.172% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 5 | 0 | €81.24 | €102.54 | 26.221% |
| Dynavax Technologies Corp | 4 | 0 | 1 | 0 | €10.35 | €26.95 | 160.384% |
| Lexicon Pharmaceuticals Inc. | 7 | 0 | 3 | 0 | €1.49 | €9.17 | 515.436% |
| Exelixis Inc. | 22 | 0 | 3 | 0 | €23.99 | €26.01 | 8.405% |
| Innoviva Inc. | 6 | 0 | 2 | 0 | €16.50 | €30.00 | 81.818% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €239.10 | €269.55 | 12.734% |
| Halozyme Therapeutics Inc. | 24 | 0 | 5 | 0 | €53.88 | €55.17 | 2.394% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.27 | €1.84 | 574.128% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.70 | €8.52 | 81.353% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €223.00 | €315.00 | 41.256% |